<< Back to News

System Formulary Update
Talquetamab-tgvs (Talvey)

Situation:

Talquetamab-tgvs (Talvey) 3 mg/1.5 mL SDV (2 mg/mL) and 40 mg/mL SDV for injection was approved for addition to the health system formulary at the November 2023 System Pharmacy and Therapeutics Committee meeting.

Background:

The following medication was reviewed: Talquetamab-tgvs (Talvey) 3 mg/1.5 mL SDV (2 mg/mL) and 40 mg/mL SDV for injection

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary:

• Talquetamab-tgvs (Talvey) 3 mg/1.5 mL SDV (2 mg/mL) and 40 mg/mL SDV for injection

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, December 19, 2023